Statistics for OR13-1 Burosumab Improves the Biochemical, Skeletal, and Clinical Symptoms of Tumor-Induced Osteomalacia Syndrome

Total visits

views
OR13-1 Burosumab Improves the Biochemical, Skeletal, and Clinical Symptoms of Tumor-Induced Osteomalacia Syndrome 145

Total visits per month

views
May 2024 0
June 2024 0
July 2024 0
August 2024 0
September 2024 0
October 2024 0
November 2024 0

File Visits

views
OR13-1 Burosumab Improves the Biochemical, Skeletal, and Clinical Symptoms of T.pdf 130

Top country views

views
United States 113
Germany 5
United Kingdom 4
Ukraine 4
Canada 2
China 2
Malaysia 1
Sweden 1

Top city views

views
Wilmington 47
Fairfield 19
Houston 7
Cambridge 5
Jacksonville 5
Kiev 4
Kiez 4
Beijing 2
Brooklyn 2
Indianapolis 2
Lake Mary 2
Toronto 2
Ann Arbor 1
Gunzenhausen 1
London 1
Phoenix 1
San Francisco 1
Scottsdale 1
Seremban 1
Stockholm 1